UK notifies WTO on amendments to the ingredient lists in UK Cosmetics Regulation 
Topic: Cosmetic ingredients restrictions UK

Date of publication: 27 November 2025

The United Kingdom notified the World Trade Organization (WTO) of a draft regulation, proposing amendments to the ingredient lists in UK Regulation. This update will restrict the use of Hexyl Salicylate and prohibit the use of 13 CMR substances.

What’s new?

On the 27th of November 2025, the United Kingdom (UK) notified the World Trade Organization (WTO) of a draft regulation amending the UK Cosmetics Regulation. This draft is titled “The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions (No. 2) Regulations 2026”. The regulation will apply to England, Wales, and Scotland.  

The proposed amendments include the addition of 13 prohibited ingredients, following its classification as CMR (Carcinogenic, Mutagenic or Toxic for Reproduction) under the GB CLP (Great Britain, Classification, Labelling and Packaging) Regulation, and 1 restricted ingredient.  

The amendment follows the advice from the Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products (SAG-CS) on the safety of using Hexyl salicylate in cosmetics.  

Impact in Cosmetics Regulation

The following substances have received a CMR classification, and will be inserted into Annex 2, becoming prohibited in cosmetic products: 

  • Sodium 3-(allyloxy)-2-hydroxypropanesulphonate (CAS No. 52556-42-0) 
  • N,N’-methylenediacrylamide (CAS No. 110-26-9) 
  • Reaction mass of 1,3-dioxan-5-ol and 1,3- dioxolan-4-ylmethanol  
  • 1,4-dichloro-2-nitrobenzene (CAS No. 89-61-2) 
  • Pyraclostrobin (CAS No. 175013-18-0) 
  • Tert-butyl 2-ethylperoxyhexanoate (CAS No. 3006-82-4) 
  • Fenpropidin (CAS No. 67306-00-7) 
  • 2-ethylhexanoic acid, monoester with propane-1,2-diol (CAS No. 85114-00-7) 
  • α,α’-propylenedinitrilodi-o-cresol (CAS No. 94-91-7) 
  • Ozone (CAS No. 10028-15-6) 
  • 2-phenylpropene; α-methylstyrene (CAS No. 98-83-9) 
  • Silver (nano) [particle diameter > 1 nm ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm] (CAS No. 7440-22-4) 
  • Nitrous oxide (CAS No. 10024-97-2) 

Hexyl salicylate (CAS No. 6259-76-3) will be added to Annex 3, with restrictions for its maximum permitted concentration as follows: 

  1. Fragrance products (spray and non-spray) – 0.1% in products intended for children 0-3 years and 2% in products intended from children above 3 and adults 
  1. Rinse-off skin and hair products – 0.1% in products intended for children 0-3 years and 0.5% in products intended from children above 3 and adults 
  1. Leave-on skin products (except fragrance products, face makeup products, lip products and deodorants (spray and non-spray)) – 0.1% in products intended for children 0-3 years and 0.3% in products intended from children above 3 and adults 
  1. Lip products – 0.1% in products intended for children 0-3 years and 0.3% in products intended from children above 3 and adults 
  1. Deodorant (spray and non-spray) – 0.3% in products intended from children above 3 and adults 
  1. Leave-on hair products (spray and non-spray) – 0.3% in products intended from children above 3 and adults 
  1. Face makeup products – 0.3% in products intended from children above 3 and adults 
  1. Toothpaste and mouthwash – 0.001% 

What now?

The draft is open for comments until the 26th of January 2026.  

The update on Annex 3 will come into force on the 15th of August 2026, and the amendment to Annex 2, will come into force on the 23rd of March 2027.  

The amendment is subject to transitional arrangements: 

  • For cosmetic products containing Hexyl salicylate, when a cosmetic product is placed on the market prior to 15thof August 2026 and complies with the past requirements of the Cosmetic Regulation, it may continue to be made available on the market until the end of the 14thof February 2027.  
  • For a cosmetic product containing any of the CMR substances, when a cosmetic product is placed on the market before the 23rd of March 2027, it may continue to be made available on the market until the end of the 22nd of September 2027. 

References:

World Trade Organization (WTO) – Committee on Technical Barriers to Trade, G/TBT/N/GBR/108

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »
Any REGULATORY QUESTION?

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »